The following posts are to be filled through walk in written test/interview on 09.09.2016 at 9:00 a.m. for different projects running in National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra. The advertised posts are purely temporary for a fixed duration and with fixed emoluments. The staff selected on the posts will not be regularized or NJIL/ICMR/Govt. will not be liable for any regularization on the regular posts advertised in due course. The appointment can be terminated any time even before the end of the contract period due to any reason. The candidate can leave the job prematurely giving one month’s notice or one month’s salary in lieu of the same.

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies ICON enjoys a strong reputation for quality and is focused on staff development. We make it our mission to attract the most diverse and creative minds into the business and we continually strive to provide opportunities for our people to excel, grow and build a great career. We understand that our greatest asset is the skills and talents of our people and they are truly what set us apart.

Post: Manager Drug Safety

The Indian Institute of Management Lucknow is fourth in the prestigious IIM family of management schools to be established in India after IIM Calcutta, IIM Ahmedabad and IIM Bangalore. The establishment of IIMs was envisioned and initiated by the first Prime Minister of India – Pandit Jawaharlal Nehru.

Caliber Technologies Pvt. Ltd. is a company formed in Aug 2001 with a focus on solutions for Pharma and biotech industries. Caliber's core competency lies in building solutions for Pharma and laboratory activities and solutions for international quality standards and regulatory norms like GLP, FDA, and GAMP. We have developed a portfolio of competencies out of this core competency.
The company's flagship product CaliberLIMS® is designed using cutting edge technologies to help the Pharma/ biotech companies to comply to the stringent international regulatory norms like Electronic Signatures and Electronic Records (21CFR PART 11), GAMP etc. Implementation of CaliberLIMS® would reduce the risk of regulatory non-conformance. It is thus an Enterprise Quality Management tool for the regulated industry. Apart from its flagship product CaliberLIMS®, Caliber offers other software solutions for the regulated industries with a suite of products such as Caliber Stability, Caliber TRIMS, Caliber EM and Caliber CLAPS. It also has other products in the pipeline like Caliber CLINSTAR (Clinical Trials LIMS), Caliber eDox (Document Management System) and Caliber CAPA. The Company's products are innovative, highly configurable, integrate well with SAP etc., and are user friendly.

1. Which of the following trademarked sustained release systems are based on encapsulated drug particles that will dissolve at various rates ?  
I.   Sequels
II.   Spansules
III.  Extentabs.
Of these
A)  I only
B)  III Only
C) I and II
D) I, II, and III

Delhi government has established Delhi Healthcare Corporation Limited (DHCL), a public limited company, under the Department of Health and Family Welfare of Government of National Capital Territory of Delhi (GNCTD). DHCL is mandated to provide administrative support services to health facilities of Delhi Govt. including procurement and ensuring availability of drugs, consumables, equipment, setting up and running of laboratory services, management of outsourced hospital services, smooth running of Aam Aadmi Mohalla clinics, technology services etc. ). DHCL will provide these services by setting up four Strategic Business Units (SBU) Procurement & Supply Chain Management Services, Hospital Management Services, Aam Aadmi Mohalla Clinic (AAMC) Management Services and Information Technology Services. To carry out the functions and tasks effectively, the Delhi Healthcare Corporation invites applications for following below mentioned posts in the prescribed format from suitable candidates on a contractual / deputation basis.

Post : Chief Manager – Procurement of Drugs & Consumables

Applications are invited from eligible candidates with Nationality/Citizenship as indicated under Para-6 of this Notice, for the Selection Posts indicated in Para-4 of this Notice. Only those Applications successfully filled through the Website ssconline.nic.in/selectionposts and Print out of Online Application along with all the required documents received in the concerned SSC Regional Office within the specified time are accepted. Procedure for Online Submission of Application consists of two stages – (i) Registration Part & (ii) Application Part.

Post : Junior Scientific Assistant

Shilpa Medicare Ltd. SEZ-Formulation Unit, we are among the fastest growing oncology formulation pharmaceutical company, looking for dynamic young energetic, creative and talented mate candidates for formulation unit at Jadcherla near Hyderabad

Tweet India Pharmaceuticals Pvt. Ltd. is being headed by Mr. A. K. Arora, who is backed up by his more than 35 years practical and successful experiences of Pharmaceutical Industry and has given his precious and valuable guidance in formulating latest strategies which is followed by many Pharmaceutical Companies, and has been the milestone for the Pharmaceutical Industries.
Mr. Arora has created history in establishing many products which are essential and are in the interest of the mankind. His last assignment for the last 22 years as one of the partner with Talent India has given the new heights, and created history in the industry.

IDPL is the largest Central Pharma Public Sector Undertaking in India with plants at Rishikesh, Gurgaon & Hyderabad and two Subsidiary Units at Chennai and Muzaffarpur.
The vision of first Prime Minister of India, Late Pt. Jawahar Lal Nehru regarding Indian Drug Industry was that “the drug industry must be in the public sector….. I think an industry of the nature of the drug industry should not be in the private sector anyhow. There are for too much exploitation of the public in this industry”. With the vision of the then Prime Minister of India, IDPL was incorporated in April, 1961 (Company Registration No. 3418 of 1961-1962 with Registrar of Companies, Delhi and having its Registered and Corporate Office at Gurgaon) with main objectives of creating self-sufficiency in respect of essential life saving medicines, to free the country from dependence on imports and to provide medicines to the millions at affordable prices and not to make millions from the medicines. IDPL was basically conceived and established as a part of Healthcare Infrastructure and has played a pioneering infra-structural role in the growth of Indian Drug Industry base.

{ DOWNLOAD AS PDF }

ABOUT AUTHOR
Komal Saini*
Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh
komalsainiks@gmail.com

ABSTRACT
Hydrogels comprises of different classes class of materials that could absorb considerable amount of water while maintaining their integrity in water having three dimensional, hydrophilic, polymeric networks. In the last few years, radical methods of preparation of hydrophilic polymers and hydrogels have evolved that may be used in the future in drug delivery applications. For successful and desirable applications, synthesis of new polymers and cross-linkers having more biocompatibility and better biodegradability would be beneficial. This review provides an overview of the different classes of hydrogels, their characterization, method of preparation, their advantages and disadvantages and cross-linking.

School of Pharmaceutical Sciences at Siksha O Anusandhan University at Bhubaneswar, one of the premier institutions of pharmaceutical education and research in the country

Post : SRF

Sun Pharma ranks amongst India's largest pharma companies We’ve built a reputation for speciality therapy leadership and faster- than-industry growth over the last 30 years. From a modest beginning with five people, our team today exceeds 13,000 and growing, put manufacturing base now spans 25 sites across the world. With a market cap of over $ 16 billion, we’re also India’s most valued pharma brand. To keep pace with our growth plans, we require for our Formulation manufacturing plant at Halol (Near Baroda):

Post: Asst manager / Executive

Applications are invited from eligible candidates for recruitment of Staff Nurses (6 Post,), Pharmacist Gr-II (2 posts), Lab Technician Gr-II (2 posts) on contract basis to work in the PHCs newly sanctioned under 13,h Finance Commission. Applications to be submitted to the D,st. Medical & Health Officer, District Hospital Premises, Vizianagaram. The last date for receiving applications is 04,09.2016 b, 5.00 P.M.

Post : Pharmacist Gr-II(02 posts)

At UnitedHealth Group, their mission is to help people live healthier lives. To achieve this goal, they are focused on building a modern, adaptable, innovative and inclusive system of health care services.
Their scale and potential to improve health makes them one of the most visible stewards of America’s vast health care system. Entrusted with both important resources and responsibilities, they are involved on a daily basis in decision-making that has life-changing consequences for millions of Americans.

Post: Associate Director - Healthcare

Evolet Healthcare Pvt. Ltd. is an international, modern and dynamic outsourcing company that specializes in the field of contract manufacturing and marketing of pharmaceutical products. The Management of the company constantly monitors innovations in the pharmaceutical industry to keep up with the ever-increasing demands on pharmaceutical products to improve and enhance the quality of services irrespective of which part of the world the client comes from.

Post: HR & Admin Executive - 1-2

Headquartered in Australia and focused exclusively on the Asia Pacific, Novotech is internationally recognized as a leading regional CRO. With the increasing pace of globalisation in drug development, Novotech’s expertise in the vibrant and fast growing Asian region has been instrumental in the success of hundreds of phase I-IV clinical trials from Australia to India. Our highly experienced 140 strong staff based in 8 countries and 15 locations across the region provide access to patients from a population base of over 1.5 billion people. This breadth of reach, supported by the most sophisticated market data commercially available, enables us to conduct extremely thorough feasibility assessments for almost any study.

Post : Sales Analyst